At the event panel titled “AI in Medicine: Accelerating Drug Discovery and Cures” Hooman Rashidi, Pitt’s associate dean of AI in medicine and executive director of the Computational Pathology & AI Center of Excellence was joined by Jonathan Steckbeck, CEO of Pitt startup Peptilogics, and Molly Johnson, senior director of data sciences at Pitt startup Avista Therapeutics, to demonstrate how Pitt innovators are harnessing AI to build powerful platforms for disease diagnosis and drug discovery.
